BioVie Inc. Fair Value Adjustment of Warrants
BioVie Inc. (BIVI) reported Fair Value Adjustment of Warrants of $1.40 million for the 12-month period ending 2025-06-30, per its S-1/A filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-08-06
- BioVie Inc. fair value adjustment of warrants for the quarter ending 2025-06-30 was $0.00.
- BioVie Inc. fair value adjustment of warrants for the quarter ending 2025-03-31 was $0.00.
- BioVie Inc. fair value adjustment of warrants for the quarter ending 2024-12-31 was $0.00.
- BioVie Inc. fair value adjustment of warrants for the quarter ending 2024-09-30 was $1.40M, a 0.00% change year-over-year.
- BioVie Inc. fair value adjustment of warrants for fiscal 2024 was $1.40M.
- BioVie Inc. fair value adjustment of warrants for fiscal 2022 was $1.40K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: S-1/A 12 month − 10-Q 9 month · filed 2026-08-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $1.40M S-1/A · filed 2026-08-06 |
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-12 | $0.00 derived: sum of 2 quarters · filed 2025-05-12 | $1.40M 10-Q · filed 2025-05-12 | $1.40M derived: sum of 4 quarters · filed 2025-05-12 |
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-11 | $1.40M 10-Q · filed 2025-02-11 | $1.40M derived: sum of 3 quarters · filed 2025-02-11 | $1.40M derived: sum of 4 quarters · filed 2025-02-11 |
| 2024-09-30 | $1.40M 10-Q · filed 2024-11-13 | $1.40M derived: sum of 2 quarters · filed 2024-11-13 | $1.40M derived: sum of 3 quarters · filed 2024-11-13 | $1.40M derived: sum of 4 quarters · filed 2024-11-13 |
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $0.00 derived: sum of 2 quarters · filed 2024-09-30 | $0.00 derived: sum of 3 quarters · filed 2024-09-30 | $1.40M 10-K · filed 2024-09-30 |
| 2024-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-14 | $0.00 derived: sum of 2 quarters · filed 2024-05-14 | $1.40M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-13 | $1.40M 10-Q · filed 2024-02-13 | ||
| 2023-09-30 | $1.40M 10-Q · filed 2023-11-08 | |||
| 2023-03-31 | $1.40M 10-Q · filed 2023-05-12 | |||
| 2022-12-31 | $1.40M 10-Q · filed 2023-02-10 | |||
| 2022-09-30 | $1.40M 10-Q · filed 2022-11-04 | |||
| 2022-06-30 | $1.40K 10-K · filed 2022-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |